Malignant melanoma: analysis of dose fractionation in radiation therapy
- PMID: 3112864
- DOI: 10.1148/radiology.164.3.3112864
Malignant melanoma: analysis of dose fractionation in radiation therapy
Abstract
Thirty-five patients with 67 measureable cutaneous or lymph node metastases from malignant melanoma were treated with radiation therapy in a variety of total doses and dose fractions. There was no correlation between total dose and response rate. However, there was a strong correlation between fraction size and response rate. There were four (9%) complete responses in 43 lesions treated with fractions less than or equal to 500 rad (5 Gy) compared with 12 (50%) complete responses in 24 lesions treated with fractions greater than 500 rad (5 Gy) (P = .0006). Initial response rate was found to correlate strongly with local control at 1 year. The results were then analyzed with respect to lesion size, cutaneous versus nodal lesions, and site of cutaneous lesion (trunk, head and neck, or extremity). Correlation between fraction size and response rate was independent of lesion size, although there were fewer complete responses with increasing lesion size. Correlation was not seen in nodal lesions but was particularly striking in cutaneous lesions. This correlation was statistically significant only for cutaneous lesions of the extremities.
Similar articles
-
The use of large fractions in radiotherapy for malignant melanoma.Radiother Oncol. 1992 Jul;24(3):195-7. doi: 10.1016/0167-8140(92)90380-d. Radiother Oncol. 1992. PMID: 1410573
-
A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan.Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):495-500. doi: 10.1016/j.ijrobp.2003.11.013. Int J Radiat Oncol Biol Phys. 2004. PMID: 15145168
-
Radiation therapy for Bowen's disease of the skin.Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):505-10. doi: 10.1016/j.ijrobp.2005.02.024. Int J Radiat Oncol Biol Phys. 2005. PMID: 16168842
-
Role of radiotherapy and hyperthermia in the management of malignant melanoma.Semin Surg Oncol. 1996 Nov-Dec;12(6):407-15. doi: 10.1002/(SICI)1098-2388(199611/12)12:6<407::AID-SSU6>3.0.CO;2-E. Semin Surg Oncol. 1996. PMID: 8914205 Review.
-
[Radiotherapy of malignant melanoma of the skin].Praxis (Bern 1994). 2001 Mar 8;90(10):397-402. Praxis (Bern 1994). 2001. PMID: 11305185 Review. German.
Cited by
-
Practice patterns for postoperative radiation therapy in patients with metastases to the long bones: a survey of the Japanese Radiation Oncology Study Group.J Radiat Res. 2021 Mar 10;62(2):356-363. doi: 10.1093/jrr/rraa133. J Radiat Res. 2021. PMID: 33454759 Free PMC article.
-
The evolving role of radiation therapy in the management of malignant melanoma.Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):645-54. doi: 10.1016/j.ijrobp.2010.12.071. Epub 2011 Apr 12. Int J Radiat Oncol Biol Phys. 2011. PMID: 21489712 Free PMC article. Review.
-
Surgery and radiotherapy in the treatment of cutaneous melanoma.Ann Oncol. 2009 Aug;20 Suppl 6(Suppl 6):vi22-9. doi: 10.1093/annonc/mdp257. Ann Oncol. 2009. PMID: 19617294 Free PMC article. Review.
-
First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma.Br J Cancer. 2016 May 24;114(11):1199-205. doi: 10.1038/bjc.2016.120. Epub 2016 May 3. Br J Cancer. 2016. PMID: 27140316 Free PMC article. Clinical Trial.
-
Profiling of plasma metabolites in canine oral melanoma using gas chromatography-mass spectrometry.J Vet Med Sci. 2015 Aug;77(8):1025-8. doi: 10.1292/jvms.14-0641. Epub 2015 May 4. J Vet Med Sci. 2015. PMID: 25843037 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical